THE WHAT? The Beauty Health Company has announced the appointment of Andrew Stanleick as President and Chief Executive Officer, effective February 7, 2022.
THE DETAILS Stanleick joins from Coty where he was most recently Executive Vice President, Americas, and Global CEO for the Kylie Jenner Beauty JV.
“I am thrilled to be joining BeautyHealth at such an exciting time for the Company. The strong business momentum, impressive category creating product and passionate community are driving impressive growth,” said Mr. Stanleick. “I look forward to working with the talented team at BeautyHealth to deliver long-term growth through brand-building initiatives, constant innovation, exciting digital marketing, continued geographic expansion and pursuit of strategic acquisitions as we capitalize on the enormous market opportunity. Our goal is to build a valuable, industry leading, global platform company in the beauty health category.”
THE WHY? Brent Saunders, Executive Chairman of BeautyHealth, commented, “Andrew’s extensive knowledge of the beauty and retail industries, his high impact global leadership, proven track record in international markets and in broadening brand awareness are invaluable as we continue to expand the beauty health category that we created. His two decades of international experience and innovative beauty marketing prowess uniquely position Andrew to build upon our platform and community to drive our growth as we capitalize on significant opportunities, especially in Asia. We are at a pivotal point in investing in our digital marketing and our infrastructure to expand our footprint globally, and Andrew will be instrumental to executing against our strategic initiatives. We are delighted to welcome him to the team.”
Aesthetic injectable companies refer to businesses or companies that specialize in manufacturing, distributing, or providing aesthetic injectable products and services. These companies focus on developing and supplying injectable substances used for cosmetic purposes, typically administered by qualified medical professionals. Aesthetic injectable companies play a crucial role in the field of aesthetic medicine and cosmetic dermatology by offering a variety of injectable products designed to enhance facial features, reduce wrinkles, and improve overall skin appearance.
Key aspects of aesthetic injectable companies include:
-
Product Development: These companies research, develop, and manufacture aesthetic injectables such as dermal fillers, botulinum toxins (e.g., Botox), collagen stimulators, and other specialized formulations. They often innovate new products to meet evolving market demands and technological advancements.
-
Distribution and Sales: Aesthetic injectable companies distribute their products through authorized channels, including healthcare providers, medical spas, and aesthetic clinics. They may also sell directly to licensed professionals who administer these treatments.
-
Regulatory Compliance: Due to the medical nature of their products, aesthetic injectable companies adhere to strict regulatory guidelines and obtain necessary approvals from health authorities (e.g., FDA in the United States) to ensure safety, efficacy, and quality standards.
-
Training and Support: Many companies provide training and educational support to healthcare professionals on the proper use, administration techniques, and safety protocols associated with their injectable products. This ensures that practitioners can deliver treatments effectively and safely.
-
Customer Support: Aesthetic injectable companies offer customer support services to healthcare providers and consumers, addressing inquiries, providing product information, and assisting with product usage and troubleshooting.
